Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Muscle Relaxant Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Skeletal Muscle Relaxant Drugs
  • 1.3.3 Facial Muscle Relaxant Drugs
• 1.4 Market Segment by Application
  • 1.4.1 Global Muscle Relaxant Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacies
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Muscle Relaxant Drugs Market Size
  • 2.1.1 Global Muscle Relaxant Drugs Revenue 2014-2025
  • 2.1.2 Global Muscle Relaxant Drugs Sales 2014-2025
• 2.2 Muscle Relaxant Drugs Growth Rate by Regions
  • 2.2.1 Global Muscle Relaxant Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Muscle Relaxant Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Muscle Relaxant Drugs Sales by Manufacturers
  • 3.1.1 Muscle Relaxant Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Muscle Relaxant Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Muscle Relaxant Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Muscle Relaxant Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Muscle Relaxant Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Muscle Relaxant Drugs Price by Manufacturers
• 3.4 Key Manufacturers Muscle Relaxant Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Muscle Relaxant Drugs Market
• 3.6 Key Manufacturers Muscle Relaxant Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Skeletal Muscle Relaxant Drugs Sales and Revenue (2014-2019)
  • 4.1.2 Facial Muscle Relaxant Drugs Sales and Revenue (2014-2019)
• 4.2 Global Muscle Relaxant Drugs Sales Market Share by Type
• 4.3 Global Muscle Relaxant Drugs Revenue Market Share by Type
• 4.4 Muscle Relaxant Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Muscle Relaxant Drugs Sales by Application

6 United States

• 6.1 United States Muscle Relaxant Drugs Breakdown Data by Company
• 6.2 United States Muscle Relaxant Drugs Breakdown Data by Type
• 6.3 United States Muscle Relaxant Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Muscle Relaxant Drugs Breakdown Data by Company
• 7.2 European Union Muscle Relaxant Drugs Breakdown Data by Type
• 7.3 European Union Muscle Relaxant Drugs Breakdown Data by Application

8 China

• 8.1 China Muscle Relaxant Drugs Breakdown Data by Company
• 8.2 China Muscle Relaxant Drugs Breakdown Data by Type
• 8.3 China Muscle Relaxant Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Muscle Relaxant Drugs Breakdown Data by Company
• 9.2 Rest of World Muscle Relaxant Drugs Breakdown Data by Type
• 9.3 Rest of World Muscle Relaxant Drugs Breakdown Data by Application
• 9.4 Rest of World Muscle Relaxant Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Muscle Relaxant Drugs Sales by Countries
  • 9.4.2 Rest of World Muscle Relaxant Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.1.4 Muscle Relaxant Drugs Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 Allergan
  • 10.2.1 Allergan Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.2.4 Muscle Relaxant Drugs Product Introduction
  • 10.2.5 Allergan Recent Development
• 10.3 Ipsen Group
  • 10.3.1 Ipsen Group Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.3.4 Muscle Relaxant Drugs Product Introduction
  • 10.3.5 Ipsen Group Recent Development
• 10.4 Teva Pharmaceuticals
  • 10.4.1 Teva Pharmaceuticals Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.4.4 Muscle Relaxant Drugs Product Introduction
  • 10.4.5 Teva Pharmaceuticals Recent Development
• 10.5 Novartis
  • 10.5.1 Novartis Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.5.4 Muscle Relaxant Drugs Product Introduction
  • 10.5.5 Novartis Recent Development
• 10.6 Johnson & Johnson
  • 10.6.1 Johnson & Johnson Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.6.4 Muscle Relaxant Drugs Product Introduction
  • 10.6.5 Johnson & Johnson Recent Development
• 10.7 Takeda Pharmaceutical
  • 10.7.1 Takeda Pharmaceutical Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.7.4 Muscle Relaxant Drugs Product Introduction
  • 10.7.5 Takeda Pharmaceutical Recent Development
• 10.8 Sun Pharmaceutical
  • 10.8.1 Sun Pharmaceutical Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.8.4 Muscle Relaxant Drugs Product Introduction
  • 10.8.5 Sun Pharmaceutical Recent Development
• 10.9 Merz Pharma
  • 10.9.1 Merz Pharma Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.9.4 Muscle Relaxant Drugs Product Introduction
  • 10.9.5 Merz Pharma Recent Development
• 10.10 Mylan
  • 10.10.1 Mylan Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Muscle Relaxant Drugs
  • 10.10.4 Muscle Relaxant Drugs Product Introduction
  • 10.10.5 Mylan Recent Development
• 10.11 Fresenius Kabi
• 10.12 Endo International
• 10.13 Par Sterile Products
• 10.14 Acorda Therapeutics
• 10.15 SteriMax Inc
• 10.16 Emcure Pharmaceuticals
• 10.17 Upsher-Smith Laboratories
• 10.18 Orient Pharma
• 10.19 Daewoong Pharmaceutical

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Muscle Relaxant Drugs Sales Channels
  • 11.2.2 Muscle Relaxant Drugs Distributors
• 11.3 Muscle Relaxant Drugs Customers

12 Market Forecast

• 12.1 Global Muscle Relaxant Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Muscle Relaxant Drugs Sales Forecast by Type
• 12.3 Global Muscle Relaxant Drugs Sales Forecast by Application
• 12.4 Muscle Relaxant Drugs Forecast by Regions
  • 12.4.1 Global Muscle Relaxant Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Muscle Relaxant Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions.
Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. Muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.
In 2019, the market size of Muscle Relaxant Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Muscle Relaxant Drugs.

This report studies the global market size of Muscle Relaxant Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Muscle Relaxant Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical

Market Segment by Product Type
Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs

Market Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Muscle Relaxant Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Muscle Relaxant Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Muscle Relaxant Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025